Both MASLD and T2DM are induced by hypothyroidism, which typically involves increased secretion of TSH but reduced circulating T3 and T4Agonists activate THR target genes, which results in increased pancreatic insulin sensitivity and reduced hepatic TG accumulation [37,38]. Here, INS is linked to type 2 diabetes mellitus.